Enrollment Surpasses Projections in International Psoriasis Studies
Case Study
Mar 04, 2019
A leading global pharmaceutical company selected IQVIA Biotech to support four large, international Phase III biologic studies in moderate to severe psoriasis. The IQVIA Biotech dermatology team was selected because of a proven patient recruitment process with a record of enrollment that could save the sponsor time and money. Successful patient recruitment strategies in 13 countries, where some are unfamiliar with advertising, surpassed enrollment projections.
You may also be interested in
Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.